Serotonin-3 Receptor Antagonist class drugs

7 results

  • akynzeo

    (Netupitant and Palonosetron)
    Helsinn Therapeutics (U.S.), Inc.
    AKYNZEO is indicated for the prevention of acute and delayed nausea and vomiting in adults undergoing initial and repeat courses of highly emetogenic cancer chemotherapy, used in combination with dexamethasone. It consists of palonosetron and netupitant (or fosnetupitant in injectable form).
    Medication Details
    Drug Interactions

  • ondansetron

    (Ondansetron)
    ACTAVIS PHARMA, INC.
    Ondansetron tablets are indicated for preventing nausea and vomiting from highly and moderately emetogenic cancer chemotherapy, radiotherapy (including total body irradiation and abdominal treatments), and postoperative settings.
    Medication Details
    Drug Interactions

  • ondansetron

    (Ondansetron)
    Natco Pharma USA LLC
    Ondansetron tablets are indicated for preventing nausea and vomiting from highly and moderately emetogenic cancer chemotherapy, specific radiation treatments, and postoperative nausea or vomiting.
    Medication Details
    Drug Interactions

  • ondansetron hydrochloride

    (Ondansetron Hydrochloride)
    Chartwell RX, LLC.
    Ondansetron oral solution is indicated for preventing nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy, specific radiotherapy approaches, and postoperative periods.
    Medication Details
    Drug Interactions

  • palonosetron

    (Palonosetron)
    NorthStar Rx LLC
    Palonosetron hydrochloride injection is indicated for preventing acute and delayed nausea and vomiting related to moderately and highly emetogenic cancer chemotherapy in adults and pediatric patients. It also prevents postoperative nausea and vomiting for up to 24 hours after surgery, but routine prophylaxis is not recommended when the risk is low.
    Medication Details
    Drug Interactions

  • palonosetron hydrochloride

    (Palonosetron Hydrochloride)
    Eugia US LLC
    Palonosetron hydrochloride injection is indicated for preventing acute and delayed nausea and vomiting in adults undergoing moderately and highly emetogenic chemotherapy, as well as for preventing postoperative nausea and vomiting. It is also indicated for pediatric patients aged 1 month to under 17 years for chemotherapy-related nausea.
    Medication Details
    Drug Interactions

  • sustol

    (granisetron)
    Heron Therapeutics, Inc.
    SUSTOL is indicated for the prevention of acute and delayed nausea and vomiting in adults undergoing moderately emetogenic chemotherapy (MEC) or anthracycline and cyclophosphamide (AC) regimens, in combination with other antiemetics.
    Medication Details
    Drug Interactions